Literature DB >> 17289495

Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.

Glenn S Murphy1, Jesse H Marymont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17289495     DOI: 10.1053/j.jvca.2006.08.011

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  15 in total

1.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

2.  Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.

Authors:  Kristin M Bompiani; Jens L Lohrmann; George A Pitoc; James W Frederiksen; George B Mackensen; Bruce A Sullenger
Journal:  Chem Biol       Date:  2014-07-24

3.  Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 4.  [Cardiopulmonary bypass in cardiac surgery].

Authors:  T Baehner; O Boehm; C Probst; B Poetzsch; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2012-10       Impact factor: 1.041

5.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03

6.  Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.

Authors:  David P Webb; Matthew T Warhoover; Susan S Eagle; James P Greelish; David X Zhao; John G Byrne
Journal:  J Extra Corpor Technol       Date:  2008-06

7.  Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia.

Authors:  John P Breinholt; Brady S Moffett; Karen M Texter; Frank F Ing
Journal:  Pediatr Cardiol       Date:  2008-04-15       Impact factor: 1.655

8.  The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.

Authors:  Yahaya Hassan; Ahmed Awaisu; Ahmad Abdulrahman Al-Meman; Noorizan Abd Aziz
Journal:  Malays J Med Sci       Date:  2008-04

9.  Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass.

Authors:  Haralabos Parissis
Journal:  J Cardiothorac Surg       Date:  2011-04-08       Impact factor: 1.637

10.  Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass.

Authors:  Shvetank Agarwal; Beth Ullom; Yasser Al-Baghdadi; Michael Okumura
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.